PhD (cum laude), VU University Medical Center, Amsterdam
MSc Epidemiology, Harvard School of Public Health, USA
BSc, MD, and FRCPC Western University
Louie AV, Haasbeek CJA, Mokhles S, et al. Predicting Overall Survival following SABR in Early-Stage Lung Cancer: Development and External Validation of The Amsterdam Model International Journal of Radiation Oncology Biology Physics 2015 May 9
Chang JY, Senan S, Paul R, Mehran RJ, Louie AV, et al. SABR versus lobectomy for operable stage I NSCLC: pooled analysis of 2 phase III randomized control trials. Lancet Oncology – 2015 May 13.
Louie AV, Senan S, Patel P, et al. When is a Biopsy-proven Diagnosis Necessary before Stereotactic Ablative Radiotherapy for Lung Cancer? A Decision Analysis. Chest – 2014 May 22.
Louie AV, Rodrigues GB, Palma DA, Senan S. Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I NSCLC in Canada. The Oncologist – 2014 Aug;19(8):880-5.
Louie AV, Lane S, Palma DA, et al. Radiotherapy for Intubated Patients with Malignant Airway Obstruction: Futile, or Facilitating Extubation? Journal of Thoracic Oncology – 2013 Nov;8(11):1365-70.